» Articles » PMID: 32457642

Dietary Copper Plays an Important Role in Maintaining Intestinal Barrier Integrity During Alcohol-Induced Liver Disease Through Regulation of the Intestinal HIF-1α Signaling Pathway and Oxidative Stress

Overview
Journal Front Physiol
Date 2020 May 28
PMID 32457642
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Impaired intestinal barrier function and oxidative stress injury play critical roles in the pathogenesis of alcoholic liver disease (ALD), and recent investigations have revealed a role for dietary copper in the liver and intestinal barrier function. Therefore, the current study investigates the mechanisms and role of dietary copper in alcohol induced liver diseases. C57BL/6 mice were used to create an alcoholic liver disease model with a Lieber-DeCarli diet containing 5% alcohol and were fed with different concentrations of dietary copper of adequate (6 ppm, CuA), marginal (1.5 ppm, CuM), or supplemental (20 ppm, CuS) amounts. Caco-2 cells were also exposed to ethanol and different concentrations of copper. Damages of the liver and intestine were evaluated by transaminases, histology staining, and protein and mRNA level, as well as cell proliferation, oxidative stress, and mitochondrial membrane potential. In animal experiments, the results indicate that an alcohol diet causes liver injury and disruption of intestinal barrier function as well as decreasing the expression of genes such as HIF-1α, occludin, SOD1, and GPX1. Supplemental dietary copper can revert these changes except for SOD1, but marginal dietary copper can worsen these changes. The cell experiments showed that proper copper supplementation can promote cell growth and reduce reactive oxygen species (ROS) production. In conclusion, supplemental dietary copper has beneficial effects on alcohol-induced intestine and liver injury, and marginal dietary copper shows detrimental effects on these parameters.

Citing Articles

A New Strategy for Dietary Nutrition to Improve Intestinal Homeostasis in Diarrheal Irritable Bowel Syndrome: A Perspective on Intestinal Flora and Intestinal Epithelial Interaction.

Wu X, Cao Y, Liu Y, Zheng J Nutrients. 2024; 16(18).

PMID: 39339792 PMC: 11435304. DOI: 10.3390/nu16183192.


Identification of diagnostic markers and molecular clusters of cuproptosis-related genes in alcohol-related liver disease based on machine learning and experimental validation.

Li J, Wang Y, Wu Z, Zhong M, Feng G, Liu Z Heliyon. 2024; 10(18):e37612.

PMID: 39315155 PMC: 11417179. DOI: 10.1016/j.heliyon.2024.e37612.


Ileum Proteomics Identifies Distinct Pathways Associated with Different Dietary Doses of Copper-Fructose Interactions: Implications for the Gut-Liver Axis and MASLD.

Xu M, Li M, Benz F, Merchant M, McClain C, Song M Nutrients. 2024; 16(13).

PMID: 38999831 PMC: 11242941. DOI: 10.3390/nu16132083.


Research progress in cuproptosis in liver cancer.

Chen L, Liu D, Tan Y Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023; 48(9):1368-1376.

PMID: 38044648 PMC: 10929866. DOI: 10.11817/j.issn.1672-7347.2023.230083.


Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease.

Yan C, Hu W, Tu J, Li J, Liang Q, Han S J Transl Med. 2023; 21(1):300.

PMID: 37143126 PMC: 10158301. DOI: 10.1186/s12967-023-04166-8.


References
1.
Rao R . Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology. 2009; 50(2):638-44. PMC: 6209509. DOI: 10.1002/hep.23009. View

2.
Aigner E, Strasser M, Haufe H, Sonnweber T, Hohla F, Stadlmayr A . A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease. Am J Gastroenterol. 2010; 105(9):1978-85. DOI: 10.1038/ajg.2010.170. View

3.
Shao T, Zhao C, Li F, Gu Z, Liu L, Zhang L . Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction. J Hepatol. 2018; 69(4):886-895. PMC: 6615474. DOI: 10.1016/j.jhep.2018.05.021. View

4.
Prabhakar N, Semenza G . Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. Physiol Rev. 2012; 92(3):967-1003. PMC: 3893888. DOI: 10.1152/physrev.00030.2011. View

5.
Altarelli M, Ben-Hamouda N, Schneider A, Berger M . Copper Deficiency: Causes, Manifestations, and Treatment. Nutr Clin Pract. 2019; 34(4):504-513. DOI: 10.1002/ncp.10328. View